Sign In
Std ccn
National std curriculum
Podcast
Newsletter
Menu
About
Our Centers
Training
Online Learning
STI News
DoxyPEP
Resources
Contact
close
About
Our Centers
Training
Online Learning
STI News
DoxyPEP
Resources
Contact
Sign In
Std ccn
National std curriculam
Podcast
Newsletter
STI News
Breaking news and newly released STI resources for clinicians!
NEW: Online Classes with CE!
Recognizing the challenges faced by healthcare providers in attending face-to-face training, the NNPTC offers free online learning and distance learning options. ...
Health Equity Considerations for Doxycycline as STIPEP
Gay, bisexual, and other men who have sex with men (GBMSM) and transgender people experience higher rates of STIs than other populations, and the disparities are even larger for GB...
HHS Releases First-Ever STI Federal Implementation Plan
The new plan outlines federal actions to reduce the burden of sexually transmitted infections in the United States through 2025.The U.S. Department of Health and Human Services (HH...
Older people in United States more likely to have AIDS at the time of HIV diagnosis
People with HIV aged 60 and over in the United States are more than twice as likely to have an AIDS-defining illness or a CD4 cell count below 200 compared to under-40s, according ...
HRC Observes National Native HIV & AIDS Awareness Day
March 20 is National Native HIV & AIDS Awareness Day, when we recognize the impact that the HIV and AIDS epidemic has had on Indigenous communities throughout our country. Accordin...
Treat Me Right
This STD Awareness Month, CDC and partners are reaching out to healthcare providers and patients alike with this very important message: Treat Me Right.What does that mean? For pro...
Powerful new PrEP and treatment drug should be effective as a small weekly pill
MK-8591 or EFdA is a novel and exceptionally long-lasting and potent HIV drug, being developed by Merck. It is a nucleoside reverse transcriptase translocation inhibitor (NRTTI). I...
1
2
3
4
>
search
envelope-o
close
arrow-circle-o-down
volume-up
chevron-down
key
linkedin-square
twitter
facebook
ellipsis-v
file-text
instagram
archive
chevron-down